| Seliciclib | IC50 | 450.0 [1] |
| (5Z)-5-(Quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-one | IC50 | 19.0 [1] |
| (5Z)-5-(Quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-one | Ki | 35.0 [1] |
| (Z)-2-((1R,2S)-2-Phenylcyclopropylamino)-5-(quinolin-6-ylmethylene)thiazol-4(5H)-one | IC50 | 2340.0 [1], 2410.0 [2], 2490.0 [3], 3340.0 [4], 6580.0 [5] |
| (Z)-2-((1R,2S)-2-Phenylcyclopropylamino)-5-(quinolin-6-ylmethylene)thiazol-4(5H)-one | Ki | 20.0 [1] |
| (5Z)-2-Imino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one | IC50 | 1280.0 [1], 1820.0 [2], 1860.0 [3], 2530.0 [4], 3100.0 [5] |
| (5Z)-2-Imino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one | Ki | 150.0 [1] |
| Alvocidib | IC50 | 30.0 [1] |
| Alvocidib | Ki | 70.0 [1] |
| Staurosporine | IC50 | 0.4 [1], 4.9 [2], 8.0 [3], 18.0 [4] |
| Olomoucine | IC50 | 4600.0 [1], 6000.0 [2], 7000.0 [3] |
| Dinaciclib | IC50 | 3.0 [1], 72.0 [2] |
| (R,Z)-2-(1-Hydroxy-3-phenylpropan-2-ylamino)-5-(quinolin-6-ylmethylene)thiazol-4(5H)-one | IC50 | 1390.0 [1], 1580.0 [2], 2030.0 [3], 3070.0 [4] |
| 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol | IC50 | 650.0 [1] |
| Vatalanib | IC50 | 10000.0 [1] |
| Nintedanib | IC50 | 10000.0 [1] |
| 6-Bromoindirubin-3'-oxime | IC50 | 320.0 [1] |
| Alsterpaullone | IC50 | 35.0 [1] |
| Purvalanol A | IC50 | 50.0 [1], 35000.0 [2] |
| 4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid | IC50 | 100000.0 [1] |
| (3Z)-3-(1H-Imidazol-5-ylmethylene)-5-methoxy-1H-indol-2(3H)-one | IC50 | 40.0 [1], 55.0 [2] |
| 6-Cyclohexylmethyloxy-5-nitroso-pyrimidine-2,4-diamine | IC50 | 2900.0 [1] |
| 6-Cyclohexylmethyloxy-5-nitroso-pyrimidine-2,4-diamine | Ki | 2500.0 [1] |
| 2-(Pyridin-4-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one | IC50 | 170.0 [1], 250.0 [2] |
| 6-O-Cyclohexylmethyl guanine | IC50 | 7000.0 [1] |
| 6-O-Cyclohexylmethyl guanine | Ki | 5000.0 [1] |
| 3-[[4-[2-[(3-Chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-1-propanol | IC50 | 5.2 [1], 17.0 [2] |
| PDGF Receptor Tyrosine Kinase Inhibitor IV | IC50 | 10000.0 [1], 100000.0 [2] |
| Cdk2 Inhibitor II | IC50 | 780.0 [1] |
| N9-Isopropyl-olomoucine | IC50 | 2000.0 [1], 9400.0 [2] |
| Aristolactam AIIIa | IC50 | 200.0 [1], 214.0 [2] |
| Oxindole-Based Inhibitor 29 | IC50 | 15.0 [1] |
| Oxindole-Based Inhibitor 22 | IC50 | 10.0 [1] |
| Oxindole-Based Inhibitor 20 | IC50 | 300.0 [1] |
| 4-[1-(2-Hydroxy-1H-indol-3-yl)ethylideneamino]benzenesulfonamide | IC50 | 2300.0 [1] |
| 4-[[5-(Dimethylamino)-2-hydroxy-1H-indol-3-yl]methylideneamino]benzenesulfonamide | IC50 | 2800.0 [1] |
| 4-[(7-Hydroxy-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-yl)methylideneamino]benzenesulfonamide | IC50 | 29.0 [1] |
| Oxindole-Based Inhibitor 60 | IC50 | 74.0 [1] |
| Oxindole-Based Inhibitor 66 | IC50 | 790.0 [1] |
| Oxindole-Based Inhibitor 81 | IC50 | 12.0 [1] |
| Oxindole-Based Inhibitor 43 | IC50 | 330.0 [1] |
| (2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amine | IC50 | 100.0 [1] |
| 4-[[5-(Isobutoxycarbonyl)-2-oxoindoline-3-ylidenemethyl]amino]benzenesulfonamide | IC50 | 19.0 [1] |
| Oxindole-Based Inhibitor 58 | IC50 | 60.0 [1], 69.0 [2] |
| Oxindole-Based Inhibitor 59 | IC50 | 230.0 [1] |
| Oxindole-Based Inhibitor 62 | IC50 | 60.0 [1] |
| TrkA Inhibitor | IC50 | 3000.0 [1] |
| N'-(Pyrrolidino[2,1-B]isoindolin-4-ON-8-YL)-N-(pyridin-2-YL)urea | IC50 | 122.0 [1], 1800.0 [2] |
| Oxindole-Based Inhibitor 27 | IC50 | 37.0 [1] |
| Oxindole-Based Inhibitor 31 | IC50 | 41.0 [1] |
| Oxindole-Based Inhibitor 49 | IC50 | 350.0 [1] |
| Oxindole-Based Inhibitor 50 | IC50 | 170.0 [1] |
| Oxindole-Based Inhibitor 56 | IC50 | 2.8 [1] |
| 2-(2-Chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-chromen-4-one | IC50 | 100.0 [1], 300.0 [2] |
| (3R)-9-Methoxy-3-methyl-1,2,3,4-tetrahydrobenzothiopheno[3,2-e][1,4]diazepin-5-one | IC50 | 12.0 [1] |
| N-[1-[(3-Fluorophenyl)methyl]indazol-5-yl]-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine | IC50 | 50000.0 [1] |
| Oxindole-Based Inhibitor 57 | IC50 | 130.0 [1] |
| 4-[(2-Hydroxy-7-methyl-1H-indol-3-yl)methylideneamino]benzenesulfonamide | IC50 | 1000.0 [1], 10000.0 [2] |
| Oxindole-Based Inhibitor 44 | IC50 | 77.0 [1] |
| Oxindole-Based Inhibitor 61 | IC50 | 51.0 [1] |
| 4-[[2-Hydroxy-4-(hydroxymethyl)-1H-indol-3-yl]methylideneamino]benzenesulfonamide | IC50 | 1700.0 [1] |
| 4-[1-(5-Chloro-2-hydroxy-1H-indol-3-yl)ethylideneamino]benzenesulfonamide | IC50 | 220.0 [1] |
| 4-[[5-(Methoxycarbonyl)-2-oxoindoline-3-ylidenemethyl]amino]benzenesulfonamide | IC50 | 12.0 [1] |
| 4-[[2-Hydroxy-6-(hydroxymethyl)-1H-indol-3-yl]methylideneamino]benzenesulfonamide | IC50 | 740.0 [1] |
| Oxindole-Based Inhibitor 40 | IC50 | 1000.0 [1] |
| Oxindole-Based Inhibitor 17 | IC50 | 1300.0 [1] |
| Oxindole-Based Inhibitor 25 | IC50 | 110.0 [1] |
| Oxindole-Based Inhibitor 26 | IC50 | 46.0 [1] |
| Oxindole-Based Inhibitor 28 | IC50 | 19.0 [1] |
| Oxindole-Based Inhibitor 30 | IC50 | 550.0 [1] |
| Oxindole-Based Inhibitor 32 | IC50 | 290.0 [1] |
| Oxindole-Based Inhibitor 35 | IC50 | 150.0 [1] |
| Oxindole-Based Inhibitor 36 | IC50 | 250.0 [1] |
| Oxindole-Based Inhibitor 39 | IC50 | 1000.0 [1] |
| Oxindole-Based Inhibitor 41 | IC50 | 290.0 [1] |
| Oxindole-Based Inhibitor 42 | IC50 | 95.0 [1] |
| Oxindole-Based Inhibitor 45 | IC50 | 210.0 [1] |
| Oxindole-Based Inhibitor 46 | IC50 | 710.0 [1] |
| 4-[(5-Amino-2-hydroxy-1H-indol-3-yl)diazenyl]benzenesulfonamide | IC50 | 1400.0 [1] |
| Oxindole-Based Inhibitor 64 | IC50 | 520.0 [1] |
| Oxindole-Based Inhibitor 65 | IC50 | 660.0 [1] |
| Oxindole-Based Inhibitor 69 | IC50 | 1000.0 [1], 10000.0 [2] |
| Oxindole-Based Inhibitor 73 | IC50 | 250.0 [1] |
| Oxindole-Based Inhibitor 74 | IC50 | 1700.0 [1] |
| Oxindole-Based Inhibitor 75 | IC50 | 87.0 [1] |
| Oxindole-Based Inhibitor 79 | IC50 | 43.0 [1] |
| 4-[(5-Chloro-2-hydroxy-7-methyl-1H-indol-3-yl)methylideneamino]benzenesulfonamide | IC50 | 1000.0 [1], 10000.0 [2] |
| 4-(2-Chlorophenyl)-9-hydroxy-6-(3-hydroxypropyl)pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione | IC50 | 250.0 [1] |
| Pyrazole-3-yl urea deriv. 15b | IC50 | 120.0 [1], 1800.0 [2] |
| [(2R)-1-[6-(3-Chloroanilino)-9-propan-2-ylpurin-2-yl]pyrrolidin-2-yl]methanol | IC50 | 430.0 [1], 620000.0 [2] |
| 2-Hydroxy-3-[(4-sulfamoylphenyl)iminomethyl]-1H-indole-5-carboxylic acid | IC50 | 150.0 [1] |
| 4-[[5-(5-Oxazolyl)-2-oxoindoline-3-ylidenemethyl]amino]benzenesulfonamide | IC50 | 17.0 [1] |
| 4-[[1-[5-(5-Oxazolyl)-2-oxoindoline-3-ylidene]ethyl]amino]benzenesulfonamide | IC50 | 7.1 [1] |
| 4-[[4-(Ethoxycarbonyl)-2-oxoindoline-3-ylidenemethyl]amino]benzenesulfonamide | IC50 | 130.0 [1] |
| 4-[[5-(3-Methylbutyryl)-2-oxoindoline-3-ylidenemethyl]amino]benzenesulfonamide | IC50 | 16.0 [1] |
| Oxindole-Based Inhibitor 82 | IC50 | 15.0 [1] |
| Oxindole-Based Inhibitor 51 | IC50 | 130.0 [1] |
| Oxindole-Based Inhibitor 63 | IC50 | 9.3 [1] |
| Oxindole-Based Inhibitor 67 | IC50 | 1000.0 [1], 10000.0 [2] |
| Oxindole-Based Inhibitor 76 | IC50 | 120.0 [1] |